U.S. Markets closed

Marrone Bio Innovations, Inc. (MBII)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.8900+0.0701 (+8.55%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.8199
Bid0.8401 x 800
Ask0.8999 x 1200
Day's Range0.8401 - 0.9105
52 Week Range0.7700 - 2.9000
Avg. Volume475,164
Market Cap156.023M
Beta (5Y Monthly)0.19
PE Ratio (TTM)N/A
EPS (TTM)-0.1050
Earnings DateNov 08, 2021 - Nov 12, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.63
  • GlobeNewswire

    Marrone Bio Prepares to Submit Registration for Next-Generation Crop Protection Product in North America

    Company Also Looks to Expand Footprint in South America with Regulatory Submission of Bionematicide Seed Treatment, MBI-206, in BrazilDAVIS, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, is on track to submit MBI-306, its next generation nematicide/insecticide, to regulatory authorities in the United States within the coming weeks. Destined for row and specialty crop market

  • Benzinga

    Monday's Marijuana Stock Movers

    GAINERS: Rhinomed (OTC:RHNMF) shares closed up 10.77% at $0.29 with an estimated market cap of $73.9M. Cannabics Pharmaceuticals (OTC:CNBX) shares closed up 7% at $0.18 with an estimated market cap of $25.9M. KushCo Holdings (OTC:KSHB) shares closed up 6.44% at $0.69 with an estimated market cap of $110.6M. CV Sciences (OTC:CVSI) shares closed up 6.11% at $0.31 with an estimated market cap of $33.5M. Cannabix Technologies (OTC:BLOZF) shares closed up 3.86% at $0.79 with an estimated market cap o

  • Simply Wall St.

    The Consensus EPS Estimates For Marrone Bio Innovations, Inc. (NASDAQ:MBII) Just Fell Dramatically

    One thing we could say about the analysts on Marrone Bio Innovations, Inc. ( NASDAQ:MBII ) - they aren't optimistic...